Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for late-onset sepsis in preterm neonates
IRCT20180404039187N7Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of pentoxifylline in neonatal sepsis (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoints: Number of hospitalized days, Duration of making CRP marker negative and 3 more. Started Apr 2020; status: completed.
02
Drugs
pentoxifylline
03
Conditions
neonatal sepsis
Beyond the preview
Go deeper on IRCT20180404039187N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180404039187N7.